CIRRUS AIRCRAFT LTD by CIRRUS AIRCRAFT LTD. Stock (OTC: CRRSF)

Latest news for CIRRUS AIRCRAFT LTD by CIRRUS AIRCRAFT LTD. (OTC:CRRSF) Stock

Asia

Markets

CRRSF

Key Takeaways:


	Cirrus Aircraft reported its half-year revenues rose nearly 12% and profits jumped almost 24% but the share price felt little benefit
	The company is trading at a discount to U.S. counterparts as investors worry about repercussions from Chinese military links through its major shareholder


By Fai Pui

Cirrus Aircraft Buffeted By Headwinds From US-China Tensions

CIRRUS AIRCRAFT LTD by CIRRUS AIRCRAFT LTD.

Cantor Fitzgerald analyst Josh Schimmer reiterates Zura Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZURA#NASDAQ">ZURA</a>) with a Overweight.

News

Reiteration

Analyst Ratings

ZURA

Cantor Fitzgerald Reiterates Overweight on Zura Bio

As of Oct. 18, 2024, two stocks in the communication services sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the <a href="https://www.benzinga.com/topic/rsi">RSI is above 70</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>. 
Here's the latest list of major overbought players in this sector.
<h3 class="wp-block-heading">T-Mobile Us Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TMUS#NASDAQ">TMUS</a>)</h3>
<ul>
<li>T-Mobile announced redemption of Sprint 7.625% notes due Feb. 15, 2025. The company's stock gained around 13% over the past month and has a <a href="https://www.benzinga.com/quote/TMUS">52-week high of $222.73</a>.</li>
<li>RSI Value: 82.35&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li>TMUS Price Action: Shares of T-Mobile Us gained 1% to close at $221.95 on Thursday.</li>
</ul>
<h3 class="wp-block-heading">Sify Technologies Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SIFY#NASDAQ">SIFY</a>)</h3>
<ul>
<li>Sify Technologies will announce financial results for the second quarter on Tuesday, Oct. 22. The company's stock gained around 54% over the past month and <a href="https://www.benzinga.com/quote/SIFY">has a 52-week high</a> of $12.30.</li>
<li>RSI Value: 70.98</li>
<li>SIFY Price Action: Shares of Sify rose 14.8% to close at $3.73 on Thursday. </li>
</ul>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/10/41379749/abbvie-is-doing-very-well-but-jim-cramers-favorite-abbott-laboratories">AbbVie Is Doing &#8216;Very Well&#8217; But Jim Cramer&#8217;s Favorite? Abbott Laboratories</a></li>
</ul>

Short Ideas

Pre-Market Outlook

Trading Ideas

SIFY

TMUS

Top 2 Tech And Telecom Stocks That May Crash In Q4

Susquehanna analyst Biju Perincheril maintains Diamondback Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FANG#NASDAQ">FANG</a>) with a Positive and lowers the price target from $237 to $233.

Price Target

FANG

Susquehanna Maintains Positive on Diamondback Energy, Lowers Price Target to $233

One step closer to achieving public reimbursement of AMVUTTRA&#xAE; for hATTR patients in Canada
MISSISSAUGA, ON, Oct. 18, 2024 /CNW/ - Alnylam Canada ULC is pleased to announce that it has signed a Letter of Intent (LOI) with the pan-Canadian Pharmaceutical Alliance (pCPA) for the public reimbursement of AMVUTTRA&#xAE; (vutrisiran injection), an RNAi therapeutic administered by quarterly subcutaneous injection, for the treatment of stage 1 or stage 2 polyneuropathy in adult patients with hereditary transthyretin-mediated amyloidosis (hATTR amyloidosis).1&nbsp;This comes following a positive recommendation from the Canadian Drug Agency (CDA) and the Institut national d'excellence en santé et services sociaux (INESSS), and signals the next step in the process where individual participating provinces and territories will start to list&nbsp;AMVUTTRA&#xAE; on their formularies.

Biotech

Global

General

ALNY

Alnylam Canada Signs LOI From Pan-Canadian Pharmaceutical Alliance For The Public Reimbursement Of AMVUTTRA For The Treatment Of Hereditary Transthyretin-Mediated Amyloidosis In Adults

Susquehanna analyst Biju Perincheril maintains Devon Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DVN#NYSE">DVN</a>) with a Positive and lowers the price target from $63 to $62.

Susquehanna Maintains Positive on Devon Energy, Lowers Price Target to $62

Telsey Advisory Group analyst Dana Telsey maintains Deckers Outdoor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DECK#NYSE">DECK</a>) with a Outperform, adjusts target to $183 from $183 (forward stock split 6:1).

DECK

Telsey Advisory Group Maintains Outperform on Deckers Outdoor, Adjusts Price Target To $183 (forward stock split 6:1)

Susquehanna analyst Biju Perincheril maintains ConocoPhillips (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COP#NYSE">COP</a>) with a Positive and lowers the price target from $147 to $144.

Susquehanna Maintains Positive on ConocoPhillips, Lowers Price Target to $144

Cantor Fitzgerald analyst Andres Sheppard initiates coverage on PureCycle Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCT#NASDAQ">PCT</a>) with a Overweight rating and announces Price Target of $14.

Initiation

Cantor Fitzgerald Initiates Coverage On PureCycle Technologies with Overweight Rating, Announces Price Target of $14

<a href="https://www.aljazeera.com/news/liveblog/2024/10/18/live-israel-says-hamas-chief-yahya-sinwar-killed-war-on-gaza-to-continue" title="https://www.aljazeera.com/news/liveblog/2024/10/18/live-israel-says-hamas-chief-yahya-sinwar-killed-war-on-gaza-to-continue">https://www.aljazeera.com/news/liveblog/2024/10/18/live-israel-says-hamas-chief-yahya-sinwar-killed-war-on-gaza-to-continue</a>

Macro Economic Events

Economics

iShares MSCI Israel Capped Investable Market Index Fund

ISRA

Hamas Senior Official Al-Hayya Says Group Is Continuing Path Until Achieving Palestinian People's Ambitions; Says Sinwar's Death Will Turn Into A Curse On 'The Occupiers'; Sinwar's Death Will Only Strengthen The Group; Israeli Hostages Will Not Return Until Aggression On Gaza Stops And Withdrawal Of Israeli Forces

Susquehanna analyst Biju Perincheril maintains APA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APA#NASDAQ">APA</a>) with a Positive and lowers the price target from $52 to $48.

Susquehanna Maintains Positive on APA, Lowers Price Target to $48

WIIM

DRUG

Bright Minds Biosciences shares are trading higher. The company announced a $35 million non-brokered private placement.

<h3>Gainers</h3>
<ul>
<li>Lion Group Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LGHL#NASDAQ">LGHL</a>) shares rose 29.8% to $0.27 during Friday's pre-market session. The company's market cap stands at $1.8 million. </li>
<li>Prestige Wealth (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PWM#NASDAQ">PWM</a>) stock moved upwards by 12.49% to $0.9. The market value of their outstanding shares is at $10.8 million. </li>
<li>UP Fintech Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TIGR#NASDAQ">TIGR</a>) stock moved upwards by 9.74% to $7.88. The market value of their outstanding shares is at $1.2 billion. </li>
<li>Yiren Digital (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YRD#NYSE">YRD</a>) stock increased by 9.54% to $6.08. The company's market cap stands at $528.5 million. </li>
<li>Garden Stage (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GSIW#NASDAQ">GSIW</a>) stock rose 7.23% to $1.63. The market value of their outstanding shares is at $25.4 million. </li>
<li>LexinFintech Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LX#NASDAQ">LX</a>) shares rose 7.01% to $3.05. The market value of their outstanding shares is at $501.4 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Pineapple Financial (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/PAPL#AMEX">PAPL</a>) shares declined by 8.3% to $0.66 during Friday's pre-market session. The company's market cap stands at $4.8 million. </li>
<li>Netcapital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NCPL#NASDAQ">NCPL</a>) shares declined by 5.15% to $1.66. The company's market cap stands at $1.2 million. </li>
<li>Santech Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STEC#NASDAQ">STEC</a>) stock declined by 4.89% to $1.51. The company's market cap stands at $42.3 million. </li>
<li>Western Alliance (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WAL#NYSE">WAL</a>) stock declined by 4.18% to $90.0. The company's market cap stands at $9.9 billion. The company's, Q3 earnings came out yesterday. </li>
<li>New York Community (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NYCB#NYSE">NYCB</a>) stock decreased by 4.12% to $11.87. The market value of their outstanding shares is at $4.9 billion. </li>
<li>MicroSectors FANG Index -3X Inverse Leveraged ETNs due January 8, 2038 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FNGD#NYSE">FNGD</a>) stock decreased by 3.62% to $19.47. 
See Also: <a href="http://www.benzinga.com/money/best-financial-services-stocks/" title="www.benzinga.com/money/best-financial-services-stocks/">www.benzinga.com/money/best-financial-services-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

FNGD

GSIW

LGHL

NCPL

NYCB

PAPL

STEC

TIGR

12 Financials Stocks Moving In Friday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>Catheter Precision (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/VTAK#AMEX">VTAK</a>) stock increased by 151.9% to $1.11 during Friday's pre-market session. The company's market cap stands at $3.1 million. </li>
<li>Akanda (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AKAN#NASDAQ">AKAN</a>) stock rose 71.13% to $1.66. The company's market cap stands at $4.7 million. </li>
<li>Tenon Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TNON#NASDAQ">TNON</a>) shares increased by 39.06% to $4.77. The company's market cap stands at $2.6 million. </li>
<li>cbdMD (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/YCBD#AMEX">YCBD</a>) stock moved upwards by 21.83% to $0.52. The company's market cap stands at $1.9 million. </li>
<li>Tevogen Bio Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TVGN#NASDAQ">TVGN</a>) stock increased by 21.01% to $1.67. The market value of their outstanding shares is at $284.9 million. </li>
<li>Carmell (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTCX#NASDAQ">CTCX</a>) shares increased by 10.77% to $0.53. The market value of their outstanding shares is at $11.1 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Orgenesis (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ORGS#NASDAQ">ORGS</a>) shares declined by 37.9% to $2.01 during Friday's pre-market session. The market value of their outstanding shares is at $9.5 million. </li>
<li>Molecular Templates (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTEM#NASDAQ">MTEM</a>) shares decreased by 30.11% to $0.65. The company's market cap stands at $4.2 million. </li>
<li>NKGen Biotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NKGN#NASDAQ">NKGN</a>) shares declined by 29.02% to $0.5. The company's market cap stands at $17.5 million. </li>
<li>Chromocell Therapeutics (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/CHRO#AMEX">CHRO</a>) shares fell 12.81% to $0.67. The company's market cap stands at $3.8 million. </li>
<li>Kazia Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KZIA#NASDAQ">KZIA</a>) shares decreased by 12.68% to $0.46. The market value of their outstanding shares is at $13.7 million. </li>
<li>Hepion Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HEPA#NASDAQ">HEPA</a>) shares declined by 11.91% to $0.66. The market value of their outstanding shares is at $3.8 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AKAN

CHRO

CTCX

HEPA

KZIA

MTEM

NKGN

ORGS

TNON

TVGN

VTAK

YCBD

12 Health Care Stocks Moving In Friday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>Jet AI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JTAI#NASDAQ">JTAI</a>) stock rose 14.9% to $0.11 during Friday's pre-market session. The market value of their outstanding shares is at $3.8 million. </li>
<li>CleanCore Solutions (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ZONE#AMEX">ZONE</a>) shares rose 13.57% to $1.59. The market value of their outstanding shares is at $12.6 million. </li>
<li>Antelope Ent Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEHL#NASDAQ">AEHL</a>) shares rose 9.3% to $0.63. The market value of their outstanding shares is at $9.2 million. </li>
<li>WANG &amp; LEE Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WLGS#NASDAQ">WLGS</a>) stock increased by 9.16% to $2.62. The company's market cap stands at $39.5 million. </li>
<li>Graphex Gr (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/GRFX#AMEX">GRFX</a>) stock moved upwards by 8.21% to $0.28. The company's market cap stands at $13.7 million. </li>
<li>Fusion Fuel Green (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HTOO#NASDAQ">HTOO</a>) stock rose 7.74% to $0.85. The company's market cap stands at $16.5 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Safe &amp; Green Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGBX#NASDAQ">SGBX</a>) shares declined by 14.1% to $1.1 during Friday's pre-market session. The company's market cap stands at $2.2 million. </li>
<li>Staffing 360 Solutions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STAF#NASDAQ">STAF</a>) shares fell 13.8% to $2.0. The company's market cap stands at $1.8 million. </li>
<li>ShiftPixy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PIXY#NASDAQ">PIXY</a>) stock fell 10.31% to $7.57. The market value of their outstanding shares is at $56.7 million. </li>
<li>Greenwave Tech Solns (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GWAV#NASDAQ">GWAV</a>) shares decreased by 8.36% to $0.51. The company's market cap stands at $10.2 million. </li>
<li>SKK Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SKK#NASDAQ">SKK</a>) stock fell 6.67% to $3.5. The company's market cap stands at $54.6 million. </li>
<li>Nixxy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NIXX#NASDAQ">NIXX</a>) shares fell 6.3% to $2.53. The company's market cap stands at $10.1 million. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AEHL

GRFX

GWAV

HTOO

JTAI

NIXX

PIXY

SGBX

STAF

WLGS

ZONE

12 Industrials Stocks Moving In Friday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>Sobr Safe (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOBR#NASDAQ">SOBR</a>) stock rose 88.7% to $15.0 during Friday's pre-market session. The market value of their outstanding shares is at $4.7 million. </li>
<li>Taoping (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TAOP#NASDAQ">TAOP</a>) stock increased by 17.89% to $0.56. The company's market cap stands at $2.5 million. </li>
<li>OneConnect Financial Tech (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OCFT#NYSE">OCFT</a>) stock rose 14.66% to $2.58. The market value of their outstanding shares is at $100.6 million. </li>
<li>MMTEC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTC#NASDAQ">MTC</a>) stock increased by 13.23% to $0.4. The company's market cap stands at $80.2 million. </li>
<li>HeartCore Enterprises (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HTCR#NASDAQ">HTCR</a>) stock moved upwards by 11.07% to $1.1. The company's market cap stands at $22.9 million. </li>
<li>ACM Research (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACMR#NASDAQ">ACMR</a>) stock increased by 8.81% to $20.68. The company's market cap stands at $1.2 billion. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Cemtrex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CETX#NASDAQ">CETX</a>) shares decreased by 15.7% to $0.35 during Friday's pre-market session. </li>
<li>Auddia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUUD#NASDAQ">AUUD</a>) stock declined by 7.11% to $0.65. The market value of their outstanding shares is at $3.6 million. </li>
<li>Phunware (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PHUN#NASDAQ">PHUN</a>) shares fell 6.15% to $7.02. The company's market cap stands at $79.6 million. </li>
<li>Zapata Computing Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZPTA#NASDAQ">ZPTA</a>) shares declined by 5.66% to $0.1. The company's market cap stands at $3.8 million. </li>
<li>Zeta Global Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZETA#NYSE">ZETA</a>) shares declined by 5.04% to $28.49. The market value of their outstanding shares is at $6.5 billion. </li>
<li>Signing Day Sports (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SGN#AMEX">SGN</a>) stock declined by 4.85% to $0.23. The company's market cap stands at $4.2 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ACMR

AUUD

CETX

HTCR

OCFT

PHUN

SOBR

TAOP

ZETA

ZPTA

12 Information Technology Stocks Moving In Friday's Pre-Market Session

Susquehanna analyst James Friedman maintains Fiserv (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FI#NYSE">FI</a>) with a Positive and raises the price target from $190 to $230.

Susquehanna Maintains Positive on Fiserv, Raises Price Target to $230

B. Riley Securities analyst Dave Kang downgrades Coherent (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COHR#NYSE">COHR</a>) from Buy to Neutral and maintains the price target from $86 to $86.

Downgrades

COHR

B. Riley Securities Downgrades Coherent to Neutral, Maintains Price Target to $86

Republic Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RBCAA#NASDAQ">RBCAA</a>) reported quarterly earnings of $1.37 per share which beat the analyst consensus estimate of $1.21 by 13.22 percent. This is a 24.55 percent increase over earnings of $1.10 per share from the same period last year.

Earnings

RBCAA

Republic Bancorp Q3 EPS $1.37 Beats $1.21 Estimate

Cantor Fitzgerald analyst Sarah James maintains Elevance Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELV#NYSE">ELV</a>) with a Overweight and lowers the price target from $600 to $485.

streetTRACKS Dow Jones U.S. Large Cap Value Index Fund

Cantor Fitzgerald Maintains Overweight on Elevance Health, Lowers Price Target to $485

The most oversold stocks in the energy sector presents an opportunity to buy into undervalued companies.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the<a href="https://www.benzinga.com/topic/rsi"> RSI is below 30</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>.
Here's the latest list of major oversold players in this sector, having an RSI near or below 30.
<h3 class="wp-block-heading">Ecopetrol SA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EC#NYSE">EC</a>)</h3>
<ul>
<li>On Oct. 16, Ecopetrol announced the pricing of cash tender offer for any and all of its outstanding 5.375% notes due 2026. The company's stock fell around 11% over the past five days and has a <a href="https://www.benzinga.com/quote/EC">52-week low of $8.13</a>.</li>
<li>RSI Value: 26.20</li>
<li>EC Price Action: Shares of Ecopetrol fell 1.1% to close at $8.15 on Thursday.</li>
<li>Benzinga Pro's real-time newsfeed alerted to<a href="https://www.benzinga.com/pro/?utm_source=BZprocontent101824&amp;t=be2bearmibe3na1"> latest EC news.</a> </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent101824&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="897" height="836" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/18075906/image-159.png" alt="" class="wp-image-602466" style="width:753px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/18075906/image-159.png 897w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/18075906/image-159-300x280.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/18075906/image-159-768x716.png 768w" sizes="(max-width: 897px) 100vw, 897px" /></a></figure>
<h3 class="wp-block-heading">Torm PLC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRMD#NASDAQ">TRMD</a>)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</h3>
<ul>
<li>On July 23, Evercore ISI Group analyst Jonathan Chappell maintained TORM with an Outperform and raised the price target from $45 to $48. The company's stock fell around 17% over the past month. It <a href="https://www.benzinga.com/quote/TRMD">has a 52-week low</a> of $26.10.</li>
<li>RSI Value: 27.08</li>
<li>TRMD Price Action: Shares of Torm fell 0.7% to close at $29.90 on Thursday.</li>
<li>Benzinga Pro&#8217;s charting tool helped identify the <a href="https://www.benzinga.com/pro/?utm_source=BZprocontent101824&amp;t=be2bearmibe3na1">trend in TRMD stock</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent101824&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="926" height="841" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/18080117/image-160.png" alt="" class="wp-image-602470" style="width:701px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/18080117/image-160.png 926w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/18080117/image-160-300x272.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/18080117/image-160-768x698.png 768w" sizes="(max-width: 926px) 100vw, 926px" /></a></figure>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/10/41379749/abbvie-is-doing-very-well-but-jim-cramers-favorite-abbott-laboratories">AbbVie Is Doing &#8216;Very Well&#8217; But Jim Cramer&#8217;s Favorite? Abbott Laboratories</a></li>
</ul>

Long Ideas

TRMD

Top 2 Energy Stocks Which Could Blast Off This Month

<h4>Key Takeaways:</h4>

<ul>
	<li>Cirrus Aircraft reported its half-year revenues rose nearly 12% and profits jumped almost 24% but the share price felt little benefit</li>
	<li>The company is trading at a discount to U.S. counterparts as investors worry about repercussions from Chinese military links through its major shareholder</li>
</ul>

By Fai Pui

Just two months after leaving the IPO runway, private jet maker&nbsp;Cirrus Aircraft Ltd.&nbsp;(OTC:<a class="ticker" href="https://www.benzinga.com/stock/CRRSF#OTC">CRRSF</a>) is struggling to pull out of a stock-price dive.

The U.S.-based maker of small aircraft, which went public in Hong Kong in July, has posted buoyant half-year earnings in its first profit report as a listed company. But even with a good&nbsp;<a href="https://www1.hkexnews.hk/listedco/listconews/sehk/2024/0827/2024082701666.pdf">report card</a>, Cirrus has been unable to escape market turbulence from U.S. sanctions against corporate China.

While investors worry Cirrus could get caught in a widening U.S. sanctions net, aviation demand from wealthy U.S. and European customers has been brisk.

Despite uncertainties in the global economy, Cirrus revenues rose 11.6% to $475 million in the first half of the year compared with the same period of 2023, while profits jumped 23.6% to $35.6 million, lifted by a growing order book and higher asking prices, according to the earnings release on Aug. 27. &nbsp;

The company delivered 20 more aircraft in the first six months of 2024 than in the year-earlier period and charged more for them. The cost of aircraft in the SR2X Series, the company&rsquo;s main product line, rose around 5% to $1.04 million and its Vision jets went up 8% to $3.33 million.

Meanwhile, Cirrus added about $8 million more in revenue from a growing business in after-sales services, aircraft parts and pilot training.&nbsp;

The earnings gave the share price an initial uplift towards HK$20, but the stock lost altitude afterwards. Last Friday it closed at HK$18.68, more than 30% below its listing price of HK$27.50.

Cirrus specializes in two types of small aircraft designed to carry around four to seven people: the SR2X series of single-engine piston planes for retail customers and the Vision Jet, which is also aimed at small-scale operators of charter flights. The U.S.-based business has become a global market leader in personal aviation, often with the owner in the cockpit as pilot. Cirrus revenues have been growing at a compound annual growth rate&nbsp;(CAGR) of 20.3% over the past three years, with profits gliding up 12.2%.

On paper, this should add up to an attractive proposition for investors. In that case, why is the Cirrus share price under pressure? The root of the problem lies in the ownership structure, not business performance.

In 2011, the U.S. founders of Cirrus Aircraft sold the business to an aviation subsidiary of a Chinese state-owned aerospace and defense conglomerate, the&nbsp;Aviation Industry Corporation of China&nbsp;(AVIC). After the IPO, the AVIC affiliate, China Aviation Industry General Aircraft, retained an 85% stake in Cirrus.

Those links could put Cirrus in the U.S. crosshairs, even though the company has not been named as a target so far and insists that it does not make aircraft or technology for the military.

The U.S. sanctioned AVIC and some of its other affiliates as early as 2021, banning Americans from buying or selling securities of targeted companies without government permission. Last year, the administration of President Joe Biden proposed new measures to screen outbound U.S. investment in China, Hong Kong and Macao that could be regarded as posing a risk to national security.

<h3>Concern About Military Connections</h3>

Cirrus was not singled out as a focus, but the company felt the need to refer to the policy in its IPO paperwork, saying its business would not be adversely affected by the move. After the listing ceremony, Cirrus CEO Zean Nielsen also sought to allay concerns, saying the company supplies private aircraft that are too small to carry weapons and are not put to military use.

The AVIC group has also played down the connections. Wang Hui, an executive at AVIC General and vice-chairman of Cirrus, said the light aircraft maker attaches great importance to compliance and operates independently of AVIC, which was described as just an investor in the business.

Market investors remain troubled, nervous about the risk of policy escalation as the U.S. heads into a presidential election. Cirrus is already being cited as a potential security threat in some quarters.

William Kim, a researcher at the Rand think tank, has said Cirrus technology could be used for military drones. George Ferguson, a senior aerospace and defense analyst at Bloomberg, also argued that customers could see a military use in Cirrus technology, even though its products are different from AVIC drones.

Clearly, a company that operates mainly in Western markets but is majority-owned by a group linked to the Chinese military was bound to come under scrutiny. As geopolitical tensions and corporate rivalries intensify, who knows where sanctions will go next. With the U.S. as its biggest market, Cirrus could be seriously affected if it finds itself in the frame. The unpredictable outlook could be a major factor behind the company&rsquo;s weak share price.

But risks aside, there is good news on the business front. In April this year U.S. regulators granted a production license for the company&rsquo;s SR10 aircraft, designed specifically for flight training. Meanwhile, combined net orders for the SR2X and Vision Jet have increased by 107 units. And the Cirrus G7, the latest model in the SR2X series, has been sold in more than 36 countries since its launch in the first half of the year. The product is not facing any bans or market restrictions for the time being.

In its results, Cirrus also outlined plans to leverage its customer base by expanding aircraft-related services and flight training, while increasing its production capacity and global market reach.

Cirrus trades at a hefty discount to its peers, reflecting worries about the policy risks.&nbsp;Textron&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TXT#NYSE">TXT</a>), a small aircraft maker listed in New York, enjoys a price-to-earnings (P/E) ratio of about 20 times, nearly double the 11 times for Cirrus, based on earnings per share of $0.11 in the first half of 2024 and assuming a similar figure in the second half.
This article is from an unpaid external contributor. It does not represent Benzinga's reporting and has not been edited for content or accuracy.

Top Stock Ideas Sent Daily — Join and Gain Your Edge

Top Stock Ideas Sent Daily — Join and Gain Your Edge

Comments

CIRRUS AIRCRAFT LTD by CIRRUS AIRCRAFT LTD.

News

Latest news for CIRRUS AIRCRAFT LTD by CIRRUS AIRCRAFT LTD. (OTC:CRRSF) Stock

Friday, September 06, 2024